These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37899386)

  • 41. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noninvasive Physiologic Assessment of Cardiac Allograft Vasculopathy Is Prognostic for Post-Transplant Events.
    Clerkin KJ; Topkara VK; Farr MA; Jain R; Colombo PC; Restaino S; Sayer G; Castillo M; Lam EY; Chernovolenko M; Yuzefpolskaya M; DeFilippis E; Latif F; Zorn E; Takeda K; Johnson LL; Uriel N; Einstein AJ
    J Am Coll Cardiol; 2022 Oct; 80(17):1617-1628. PubMed ID: 36265957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy".
    Pighi M; Gratta A; Marin F; Bellamoli M; Lunardi M; Fezzi S; Zivelonghi C; Pesarini G; Tomai F; Ribichini F
    Transplant Rev (Orlando); 2020 Oct; 34(4):100569. PubMed ID: 32739137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiogenic shock and coronary endothelial dysfunction predict cardiac allograft vasculopathy after heart transplantation.
    Lopez-Fernandez S; Manito-Lorite N; Gómez-Hospital JA; Roca J; Fontanillas C; Melgares-Moreno R; Azpitarte-Almagro J; Cequier-Fillat A
    Clin Transplant; 2014 Dec; 28(12):1393-401. PubMed ID: 25284267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients.
    Asleh R; Briasoulis A; Pereira NL; Boilson BA; Edwards BS; Adigun R; Maltais S; Daly RC; Lerman A; Kushwaha SS
    ESC Heart Fail; 2018 Dec; 5(6):1118-1129. PubMed ID: 30019530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac transplant vasculopathy.
    Aranda JM; Hill J
    Chest; 2000 Dec; 118(6):1792-800. PubMed ID: 11115475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of polyreactive innate clones among graft--infiltrating B cells in human cardiac allograft vasculopathy.
    Chatterjee D; Moore C; Gao B; Clerkin KJ; See SB; Shaked D; Rogers K; Nunez S; Veras Y; Addonizio L; Givertz MM; Naka Y; Mancini D; Vasilescu R; Marboe C; Restaino S; Madsen JC; Zorn E
    J Heart Lung Transplant; 2018 Mar; 37(3):385-393. PubMed ID: 29055600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative 3D Analysis of Coronary Wall Morphology in Heart Transplant Patients: OCT-Assessed Cardiac Allograft Vasculopathy Progression.
    Chen Z; Pazdernik M; Zhang H; Wahle A; Guo Z; Bedanova H; Kautzner J; Melenovsky V; Kovarnik T; Sonka M
    Med Image Anal; 2018 Dec; 50():95-105. PubMed ID: 30253306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantation: insights from systematic intravascular ultrasound imaging.
    Tuzcu EM; De Franco AC; Goormastic M; Hobbs RE; Rincon G; Bott-Silverman C; McCarthy P; Stewart R; Mayer E; Nissen SE
    J Am Coll Cardiol; 1996 Mar; 27(4):839-46. PubMed ID: 8613612
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative flow ratio computed from invasive coronary angiography as a predictor for cardiac allograft vasculopathy after cardiac transplant.
    Shah H; Lee I; Rao S; Suddath W; Rodrigo M; Mohammed S; Molina E; García-Garcia HM; Kenigsberg BB
    Int J Cardiovasc Imaging; 2024 Feb; 40(2):451-458. PubMed ID: 38117378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical utility of intravascular ultrasound in the assessment of coronary allograft vasculopathy: a review.
    Logani S; Saltzman HE; Kurnik P; Eisen HJ; Ledley GS
    J Interv Cardiol; 2011 Feb; 24(1):9-14. PubMed ID: 21029179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative coronary computed tomography angiography for the detection of cardiac allograft vasculopathy.
    Foldyna B; Sandri M; Luecke C; Garbade J; Gohmann R; Hahn J; Fischer J; Gutberlet M; Lehmkuhl L
    Eur Radiol; 2020 Aug; 30(8):4317-4326. PubMed ID: 32179995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for early development of cardiac allograft vasculopathy by intravascular ultrasound.
    Moayedi Y; Fan CPS; Tremblay-Gravel M; Miller RJH; Kawana M; Henricksen E; Parizo J; Wainwright R; Fearon WF; Ross HJ; Khush KK; Teuteberg JJ
    Clin Transplant; 2020 Nov; 34(11):e14098. PubMed ID: 32970884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice.
    Masetti M; Potena L; Nardozza M; Prestinenzi P; Taglieri N; Saia F; Pece V; Magnani G; Fallani F; Coccolo F; Russo A; Rapezzi C; Grigioni F; Branzi A
    Am J Transplant; 2013 May; 13(5):1217-26. PubMed ID: 23621161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
    Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA
    Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Invasive Intracoronary Imaging of Cardiac Allograft Vasculopathy: Established Modalities and Emerging Technologies.
    Shahandeh N; Parikh RV
    Interv Cardiol Clin; 2023 Apr; 12(2):269-280. PubMed ID: 36922067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of early atherosclerosis in de novo heart transplant recipients: analysis with intravascular ultrasound-derived radiofrequency analysis.
    König A; Kilian E; Rieber J; Schiele TM; Leibig M; Sohn HY; Reichart B; Klauss V
    J Heart Lung Transplant; 2008 Jan; 27(1):26-30. PubMed ID: 18187083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation.
    Asleh R; Briasoulis A; Smith B; Lopez C; Alnsasra H; Pereira NL; Edwards BS; Clavell AL; Stulak JM; Locker C; Kremers WK; Daly RC; Lerman A; Kushwaha SS
    J Card Fail; 2021 May; 27(5):542-551. PubMed ID: 33962742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PET Assessment of Cardiac Allograft Vasculopathy.
    Chih S; Wiefels CC; Beanlands RSB
    Semin Nucl Med; 2021 Jul; 51(4):349-356. PubMed ID: 33483000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.